home.aspx

 
. home.aspx home.aspx

ARCHIVED NEWS


    OBALON ENTERS INTO A DISTRIBUTION AGREEMENT FOR QATAR

    Dec 18, 2019

    Obalon Therapeutics, Inc. a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has entered into a one-year agreement with Al Danah Medical Company (“Al Dana...


    READ MORE

    /news-article.aspx?ID=36073607

    MORE THAN 130 HAVE APPLIED TO RUN JUST 14 MEDICAL CANNABIS ‘PHARMACIES’ IN UTAH

    Dec 18, 2019

    More than 130 have applied to run 14 medical cannabis “pharmacies” that will be located across the state. The Utah Department of Health told FOX 13 the applications will now be reviewed, and the agency said a committee expects to select the winning bids by January. The winners will run c...


    READ MORE

    /news-article.aspx?ID=36083608

    95 VISUAL ANNOUNCES LAUNCH OF BLUE RIVER PHARMACY’S NEW WEBSITE

    Dec 18, 2019

    95Visual is pleased to announce the launch of Blue River Pharmacy’s new website. The primary goal during the process was to improve the navigation of Blue River’s vast product offering. Specifically, Blue River wanted an exceptionally organized website with easy-to-read text for all pati...


    READ MORE

    /news-article.aspx?ID=36093609

    ANTIBE ENGAGES GLOBAL CMO TO SUPPORT PLANNED PAIN DRUG PARTNERSHIP LIKE

    Dec 16, 2019

    Toronto, Canada-based Antibe Therapeutics is running a Phase IIb clinical trial of ATB-346, a hydrogen sulfide-releasing derivative of naproxen, to generate more efficacy and metabolism data. Antibe designed ATB-346 to deliver the positive effects on pain and inflammation that make naproxen a widely...


    READ MORE

    /news-article.aspx?ID=36043604

    8 BIOPHARMA TRENDS TO WATCH IN 2020

    Dec 16, 2019

    2019 saw a new record set for a list price of a prescription therapy—$2.1 million for the gene therapy Zolgensma® launched by AxeVis, a Novartis Company—and resulting renewed concerns over the price of treatments and whether politicos will ever be able to address the issue as the nat...


    READ MORE

    /news-article.aspx?ID=36053605

    NOVARTIS AXES ASTHMA DRUG FEVIPIPRANT AFTER MORE TRIAL WOES

    Dec 16, 2019

    It’s nearly always bad news when pharma companies provide an “update” about a trial – and the statement today from Novartis about its asthma drug fevipiprant must make bleak reading for all those involved in its development. The Swiss firm has abandoned development of fevipip...


    READ MORE

    /news-article.aspx?ID=36063606

    KROGER AND WALGREENS TO BUY PRODUCTS TOGETHER TO CUT COSTS

    Dec 12, 2019

    Grocery store Kroger and drug store Walgreens are teaming up. In an effort to cut supplier costs, the two companies want to start buying merchandise together, CNBC reported. The chain retailers will call this partnership the Retail Procurement Alliance, and will have them identifying overlap in prod...


    READ MORE

    /news-article.aspx?ID=36013601

    HOSPITAL PHARMACY: STREAMLINE PROCESSES FOR BETTER PATIENT CARE

    Dec 12, 2019

    In the year ahead, health care promises to be a central issue in the 2020 election. According to a report issued this week at the 2o19 American Society of Health System Pharmacists Midyear Clinical Meeting & Exposition  from McKesson RxO, which detailed the major trends and challenges in he...


    READ MORE

    /news-article.aspx?ID=36023602

TRENDING NEWS


    CIVICA RX PARTNERS WITH THERMO FISHER SCIENTIFIC TO DEVELOP AND MANUFACTURE DRUGS WITH A HISTORY OF DRUG SHORTAGES

    Jan 16, 2020

    Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufac...


    READ MORE

    /news-article.aspx?ID=36303630

    NEW VETERINARY MEDICINES REGULATION

    Jan 16, 2020

    A new Veterinary Medicines Regulation (Regulation (EU) 2019/6) has been introduced to modernise the existing rules on the authorisation and use of veterinary medicines in the European Union (EU). This becomes applicable on 28 January 2022. The regulation contains new measures for increasing the avai...


    READ MORE

    /news-article.aspx?ID=36313631

    OPTUM DRIVES UNITEDHEALTH’S BETTER-THAN-EXPECTED EARNINGS

    Jan 16, 2020

    In a year when healthcare costs continued to increase, UnitedHealth Group reported better-than-expected results at the end of 2019. The company reported earnings of $19.68 billion in 2019, up 13 percent year-over-year. UnitedHealth saw improving margins in most of its business segments, with its Opt...


    READ MORE

    /news-article.aspx?ID=36323632

    GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

    Jan 14, 2020

    The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England an...


    READ MORE

    /news-article.aspx?ID=36273627

    POLL: UTAH VOTERS BACK CAP ON CO-PAYS FOR INSULIN PRESCRIPTIONS

    Jan 14, 2020

    The skyrocketing cost of prescription drugs has become a bipartisan issue among voters, and Utahns overwhelmingly back a plan to help diabetics overcome the cost of life-saving insulin. A new poll from UtahPolicy.com Y-2 Analytics finds 4 out of 5 registered voters would support legislation to cap o...


    READ MORE

    /news-article.aspx?ID=36283628

    ROCHE AND ILLUMINA FORGE GENOMICS ALLIANCE FOR CANCER TESTING

    Jan 14, 2020

    Roche missed out on acquiring next-generation sequencing (NGS) specialist Illumina via a hostile takeover a few years back, but has compensated for that with a 15-year alliance focusing on cancer genomics. The new deal comes after Illumina called off a $1.2 billion merger agreement with another NGS ...


    READ MORE

    /news-article.aspx?ID=36293629

    FIVE WAYS PHARMA IS LEVERAGING DIGITAL THERAPEUTICS TO DEMONSTRATE VALUE TO HEALTH PLANS

    Jan 10, 2020

    Some estimates now put the cost of developing a new drug at nearly $2.9 billion. Adding to this financial pressure, pharmaceutical companies have little control over what CMS, health plans and PBMs will agree to pay for approved drugs, or if their new drugs will be listed on formularies—often ...


    READ MORE

    /news-article.aspx?ID=36243624

    NEW UNDERSTANDING OF ANTIBIOTIC SYNTHESIS

    Jan 10, 2020

    Researchers at McGill University's Faculty of Medicine have made important strides in understanding the functioning of enzymes that play an integral role in the production of antibiotics and other therapeutics. "Many of the medicines that we rely on today are natural products, made by the E...


    READ MORE

    /news-article.aspx?ID=36253625

    BAYER, EXSCIENTIA TO EXPLORE AI IN DRUG DISCOVERY

    Jan 10, 2020

    A new collaboration between Bayer and UK-based Exscientia is set to accelerate the discovery of small molecule drugs, focused on cardiovascular disease and oncology. The companies have announced that they will use artificial intelligence (AI) to further the development of drug candidates for three o...


    READ MORE

    /news-article.aspx?ID=36263626

    GALEN TAKES OVER POA PHARMA, EXPANDS REACH

    Jan 08, 2020

    Irish pharma firm Galen has announced the completion of its POA Pharma (POA) acquisition. The company has stated that the multi-million pound takeover will help to “significantly expand” its global reach and product portfolio in exciting new therapy areas, such as rare metabolic disease....


    READ MORE

    /news-article.aspx?ID=36213621

    VERACYTE ANNOUNCES BIOPHARMACEUTICAL COLLABORATION WITH ACERTA PHARMA

    Jan 08, 2020

    today announced a multi-year partnership with Acerta Pharma, the hematology research and development arm of AstraZeneca (LSE/STO/NYSE: AZN), to provide genomic information that will support the biopharmaceutical company’s development of oncology therapeutics. Financial and other terms of the c...


    READ MORE

    /news-article.aspx?ID=36223622

    THE ADVANTAGES OF FLOW CYTOMETRY FOR COUNTING BACTERIA IN PROBIOTICS

    Jan 08, 2020

    In 2001, a joint FAO/WHO working group defined probiotics as “live micro-organisms that, when administered in adequate amounts, confer a health benefit on the host.”  Each of the key terms, ‘live’, ‘adequate amounts’ and ‘health benefit’ are, in f...


    READ MORE

    /news-article.aspx?ID=36233623

    BENZER PHARMACY GROUP AND QUALITYCARE PHARMACIES INK DEAL

    Jan 06, 2020

    Tonya Shackelford, Benzer Pharmacy, President, “We are thrilled that QualityCare Pharmacies has joined our GPO Model. QualityCare members will benefit from the comprehensive healthcare program and preferred pricing and pharmacy management model driven through Benzer. Not to mention, Benzer off...


    READ MORE

    /news-article.aspx?ID=36183618

    GOOGLE’S AI SYSTEM CAN DETECT BREAST CANCER BETTER THAN DOCTORS

    Jan 06, 2020

    An artificial intelligence (AI) system developed by Google reportedly surpasses expert radiologists in accurately interpreting mammograms from screening programs, according to a new study published in Nature. In the study, which tested the accuracy of the system and developed through a collaboration...


    READ MORE

    /news-article.aspx?ID=36193619

    FDA GREENLIGHTS FIRST GENERICS OF BLOOD THINNER

    Jan 06, 2020

    Eliquis (apixaban) is an anticoagulant used for the treatment of blood clots and prevention of stroke in people with nonvalvular atrial fibrillation, marketed by Bristol-Myers Squibb and Pfizer. Indications of the drug product also include the prevention and treatment of deep vein thrombosis, which ...


    READ MORE

    /news-article.aspx?ID=36203620

    MACHINE LEARNING PLATFORMS GENERATES MORE ALERTS FOR DRUG ERRORS

    Jan 02, 2020

    A new machine learning platform can generate clinically valid alerts for medication errors that might be missed with existing clinical decision support (CDS) systems, according to a study published in the January issue of The Joint Commission Journal on Quality and Patient Safety. Dr Ronen Rozenblum...


    READ MORE

    /news-article.aspx?ID=36163616

SPOTLIGHT

Last week Pharmaceutical Research and Manufacturers of America (PhRMA) released an infographic depicting how new drug development is actually harder than rocket science. According to PhRMA, "while it may sound counterintuitive, as our understanding of science grows, so does the complexity of develop

RESOURCES

Events